Esculetin, a Coumarin Derivative, Inhibits Aldose Reductase Activity in Vitro and Cataractogenesis in Galactose-Fed Rats

Overview

Journal Biomol Ther (Seoul)

Specialty Pharmacology

Date 2016 Feb 24

PMID 26902086

Citations 10

Authors

Chan-Sik Kim

JungHyun Kim

Yun Mi Lee

Eunjin Sohn

Jin Sook Kim

Affiliations

Soon will be listed here.

Abstract

Naturally occurring coumarin compounds have received substantial attention due to their pharmaceutical effects. Esculetin is a coumarin derivative and a polyphenol compound that is used in a variety of therapeutic and pharmacological strategies. However, its effect on aldose reductase activity remains poorly understood. In this study, the potential beneficialeffects of esculetin on lenticular aldose reductase were investigated in galactose-fed (GAL) rats, an animal model of sugar cataracts. Cataracts were induced in Sprague-Dawley (SD) rats via a 50% galactose diet for 2 weeks, and groups of GAL rats were orally treated with esculetin (10 or 50 mg/kg body weight). In vehicle-treated GAL rats, lens opacificationwas observed, and swelling and membrane rupture of the lens fibercells were increased. Additionally, aldose reductase was highly expressed in the lens epithelium and superficialcortical fibersduring cataract development in the GAL rats. Esculetin reduced rat lens aldose reductase (RLAR) activity in vitro, and esculetin treatment significanty inhibited lens opacity, as well as morphological alterations, such as swelling, vacuolation and liquefaction of lens fibers,via the inhibition of aldose reductase in the GAL rats. These results indicate that esculetin is a useful treatment for galactose-induced cataracts.

Citing Articles

Antioxidant capacity sources of soils under different land uses.

Cwielag-Piasecka I, Lyczko J, Jamroz E, Kocowicz A, Kawalko D Sci Rep. 2024; 14(1):8394.

PMID: 38600181 PMC: 11006951. DOI: 10.1038/s41598-024-58994-9.

Discovery of natural products to block SARS-CoV-2 S-protein interaction with Neuropilin-1 receptor: A molecular dynamics simulation approach.

Alshawaf E, Hammad M, Marafie S, Ali H, Al-Mulla F, Abubaker J Microb Pathog. 2022; 170:105701.

PMID: 35963279 PMC: 9364730. DOI: 10.1016/j.micpath.2022.105701.

Therapeutic effect of Keap1-Nrf2-ARE pathway-related drugs on age-related eye diseases through anti-oxidative stress.

Cai Z, Fu M, Liu K, Duan X Int J Ophthalmol. 2021; 14(8):1260-1273.

PMID: 34414093 PMC: 8342288. DOI: 10.18240/ijo.2021.08.19.

Prevention of Diabetic Complications by Walnut Leaf Extract via Changing Aldose Reductase Activity: An Experiment in Diabetic Rat Tissue.

Abbasi Z, Jelodar G, Geramizadeh B J Diabetes Res. 2020; 2020:8982676.

PMID: 32879893 PMC: 7448230. DOI: 10.1155/2020/8982676.

Sciatic Nerve Structural and Functional Recovery with Extract of Phyllanthus amarus and Esculetin in STZ-Induced Hyperglycemic Rats.

Srilatha K, Reddy K Ann Neurosci. 2020; 26(3-4):17-29.

PMID: 32843829 PMC: 7418574. DOI: 10.1177/0972753120911840.

References

Brubaker A, Deruiter J, Whitmer W . Synthesis and rat lens aldose reductase inhibitory activity of some benzopyran-2-ones. J Med Chem. 1986; 29(6):1094-9. DOI: 10.1021/jm00156a031. View

Kim N, Kim Y, Lee Y, Jang D, Kim J . Inhibition of aldose reductase and xylose-induced lens opacity by puerariafuran from the roots of Pueraria lobata. Biol Pharm Bull. 2010; 33(9):1605-9. DOI: 10.1248/bpb.33.1605. View

Murata M, Ohta N, Sakurai S, Alam S, Tsai J, Kador P . The role of aldose reductase in sugar cataract formation: aldose reductase plays a key role in lens epithelial cell death (apoptosis). Chem Biol Interact. 2001; 130-132(1-3):617-25. DOI: 10.1016/s0009-2797(00)00289-1. View

UNAKAR N, Tsui J . Inhibition of galactose-induced alterations in ocular lens with sorbinil. Exp Eye Res. 1983; 36(5):685-94. DOI: 10.1016/0014-4835(83)90106-9. View

Kawanishi K, Ueda H, Moriyasu M . Aldose reductase inhibitors from the nature. Curr Med Chem. 2003; 10(15):1353-74. DOI: 10.2174/0929867033457304. View

KINOSHITA J, Kador P, Catiles M . Aldose reductase in diabetic cataracts. JAMA. 1981; 246(3):257-61. View

KINOSHITA J . Mechanisms initiating cataract formation. Proctor Lecture. Invest Ophthalmol. 1974; 13(10):713-24. View

Subramaniam S, Ellis E . Esculetin-induced protection of human hepatoma HepG2 cells against hydrogen peroxide is associated with the Nrf2-dependent induction of the NAD(P)H: Quinone oxidoreductase 1 gene. Toxicol Appl Pharmacol. 2010; 250(2):130-6. DOI: 10.1016/j.taap.2010.09.025. View

Wang Z, Ling B, Zhang R, Liu Y . Docking and molecular dynamics study on the inhibitory activity of coumarins on aldose reductase. J Phys Chem B. 2008; 112(32):10033-40. DOI: 10.1021/jp8033227. View

10.

Veeresham C, Rama Rao A, Asres K . Aldose reductase inhibitors of plant origin. Phytother Res. 2013; 28(3):317-33. DOI: 10.1002/ptr.5000. View

11.

Lee J, Kim N, Nam J, Lee Y, Jang D, Kim Y . Scopoletin from the flower buds of Magnolia fargesii inhibits protein glycation, aldose reductase, and cataractogenesis ex vivo. Arch Pharm Res. 2010; 33(9):1317-23. DOI: 10.1007/s12272-010-0904-z. View

12.

Egan D, OKennedy R, Moran E, Cox D, Prosser E, Thornes R . The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev. 1990; 22(5):503-29. DOI: 10.3109/03602539008991449. View

13.

Tomlinson D, Stevens E, Diemel L . Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol Sci. 1994; 15(8):293-7. DOI: 10.1016/0165-6147(94)90010-8. View

14.

Lin W, Wang C, Tsai Y, Liu C, Hwang J, Tseng T . Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol. 2000; 74(8):467-72. DOI: 10.1007/s002040000148. View

15.

Patterson J, BUNTING K . Sugar cataracts, polyol levels and lens swelling. Doc Ophthalmol. 1966; 20:64-72. DOI: 10.1007/BF00165406. View

16.

Kok S, Yeh C, Chen M, Yen-Ping Kuo M . Esculetin enhances TRAIL-induced apoptosis through DR5 upregulation in human oral cancer SAS cells. Oral Oncol. 2009; 45(12):1067-72. DOI: 10.1016/j.oraloncology.2009.07.018. View

17.

de la Fuente J, Manzanaro S . Aldose reductase inhibitors from natural sources. Nat Prod Rep. 2003; 20(2):243-51. DOI: 10.1039/b204709h. View

18.

Kato A, Minoshima Y, Yamamoto J, Adachi I, Watson A, Nash R . Protective effects of dietary chamomile tea on diabetic complications. J Agric Food Chem. 2008; 56(17):8206-11. DOI: 10.1021/jf8014365. View

19.

Kador P, KINOSHITA J . Diabetic and galactosaemic cataracts. Ciba Found Symp. 1984; 106:110-31. DOI: 10.1002/9780470720875.ch7. View

20.

Peyroux J, Sternberg M . Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol Biol (Paris). 2006; 54(7):405-19. DOI: 10.1016/j.patbio.2006.07.006. View